Main
>
ONCOLOGY (**)
>
Breast Cancer>MET ***
>
Treatment
>
Co: USA. A. BevacizuMAb BioSimilar+
>
(*) EU Approval Date: 2018. 01.18
(*) EU Approval Date: 2018. 01.18's products
This section has no products